ProCE Banner Activity

CE

Improving Clinical and Economic Outcomes in Hyperkalemia: Managed Care Considerations for Pharmacy Professionals

Multimedia

Interactive on-demand webinar featuring expert insights into the management of hyperkalemia to improve clinical and economic outcomes.

Pharmacists : 1.50 contact {hours} ({0.15} CEUs)

Released: May 12, 2022

Expiration: May 11, 2023

No longer available for credit.

Share

Faculty

Katherine Di Palo

Katherine Di Palo, PharmD

Assistant Professor of Medicine
Hospital Medicine
Albert Einstein College of Medicine
Clinical Program Manager
Hospital Readmissions Reduction Program
Montefiore Medical Center
Bronx, New York

Michelle M. Richardson

Michelle M. Richardson, PharmD, BCPS

Special and Scientific Staff
Tufts Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Target Audience

The target audience for this activity is pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with or at risk for hyperkalemia as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify causes, risk factors, clinical complications, and economic consequences of hyperkalemia
  • Evaluate traditional and novel treatment options for hyperkalemia, including the efficacy and safety of available agents
  • Design safe and effective treatment plans for hyperkalemia with an oral potassium binder

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Katherine Di Palo, PharmD, FAHA, FHFSA, BCACP, BCGP, has disclosed that she has received consulting fees and funds for research support from Vifor.

Michelle Richardson, PharmD, BCPS, has disclosed that she receives salary from Dialysis Clinic, Inc.

Staff Disclosure

ProCE staff and planners have no relevant conflicts of interest to report.

Instructions for Credit

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-125-H01-P has been assigned to this home study, knowledge-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 65% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Disclosure of Unlabeled Use

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 12, 2022, through May 11, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Additional Information

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 12, 2022, through May 11, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.

 

Goal


The goal of this activity is to improve the knowledge and competence of learners about the causes, risk factors, and clinical complications of hyperkalemia, novel treatment options for hyperkalemia, and the necessary information to design safe and effective treatment plans for patients with hyperkalemia.